Gerstein Hertzel C, Capes Sarah E
Department of Medicine and the Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada.
Semin Vasc Med. 2002 May;2(2):165-74. doi: 10.1055/s-2002-32040.
Although diabetes is a strong independent risk factor for cardiovascular events, this risk is not confined to glucose levels above the diagnostic threshold for diabetes. Rather, there is now a growing consensus that the risk of cardiovascular events rises progressively as the fasting and postprandial glucose levels rise from the clearly normal range right into the diabetes range. Hence, dysglycemia (i.e., any elevated fasting or glucose level) is a progressive, continuous risk factor for cardiovascular events. In this respect it resembles every other well-established and progressive cardiovascular risk factor, such as age, LDL cholesterol, systolic and diastolic blood pressure, degree of smoking, albumin excretion, and body mass index. Whether or not strategies designed to normalize glucose levels in people with either diabetes or lesser degrees of dysglycemia will also reduce cardiovascular risk remains to be established. The results of several large international trials of glucose lowering in dysglycemic individuals should clarify the cardiovascular benefits of such an approach within the next few years.
尽管糖尿病是心血管事件的一个强大独立危险因素,但这种风险并不局限于高于糖尿病诊断阈值的血糖水平。相反,现在越来越多的共识是,随着空腹和餐后血糖水平从明显正常范围逐渐升高直至进入糖尿病范围,心血管事件的风险也在逐步上升。因此,血糖异常(即任何空腹或血糖水平升高)是心血管事件的一个渐进性、持续性危险因素。在这方面,它类似于其他所有已确立的渐进性心血管危险因素,如年龄、低密度脂蛋白胆固醇、收缩压和舒张压、吸烟程度、白蛋白排泄量以及体重指数。旨在使糖尿病患者或血糖异常程度较轻者的血糖水平正常化的策略是否也能降低心血管风险,仍有待确定。未来几年内,几项针对血糖异常个体进行降糖治疗的大型国际试验结果应能阐明这种方法对心血管的益处。